Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: Randomized double blind trial

Journal of Internal Medicine

Volumn 264, Issue 6, 2008, Pages 599-609

  Jorde, R ^a,b   Sneve, M ^b   Figenschau, Y ^a,b   Svartberg, J ^a,b   Waterloo, K ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Depression; Obesity; Vitamins

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; DECRISTOL; NYCOPLUS CALCIUM; PARATHYROID HORMONE; PLACEBO; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SYMPTOM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION;

ADULT; AGED; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DEPRESSION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PARATHYROID HORMONE; PSYCHIATRIC STATUS RATING SCALES; STATISTICS, NONPARAMETRIC; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; YOUNG ADULT;

EID: 55949104381     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.02008.x     Document Type: Article

References (27)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007 357 : 266 81.
2. Eyles D, Brown J, Mackay-Sim A, McGrath J, Feron F. Vitamin D3 and brain development. Neuroscience 2003 118 : 641 53.
3. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002 13 : 100 5.
4. McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 2008 22 : 982 1001.
5. Stumpf WE, Sar M, Clark SA, DeLuca HF. Brain target sites for 1,25-dihydroxyvitamin D3. Science 1982 215 : 1403 5.
6. Zehnder D, Bland R, Williams MC et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001 86 : 888 94.
7. Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 2007 460 : 202 5.
8. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006 14 : 1032 40.
9. Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 2007 26 : 551 4.
10. Schlager D, Schwartz JE, Bromet EJ. Seasonal variations of current symptoms in a healthy population. Br J Psychiatry 1993 163 : 322 6.
11. Gloth FM III., Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 1999 3 : 5 7.
12. Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology 1998 135 : 319 23.
13. Dumville JC, Miles JN, Porthouse J, Cockayne S, Saxon L, King C. Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women. J Nutr Health Aging 2006 10 : 151 3.
14. Harris S, Dawson-Hughes B. Seasonal mood changes in 250 normal women. Psychiatry Res 1993 49 : 77 87.
15. Snijder MB, van Dam RM, Visser M et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005 90 : 4119 23.
16. Dixon JB, Dixon ME, O'Brien PE. Depression in association with severe obesity: changes with weight loss. Arch Intern Med 2003 163 : 2058 65.
17. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961 4 : 225 36.
18. Ainsworth BE, Macera CA, Jones DA et al. Comparison of the 2001 BRFSS and the IPAQ Physical Activity Questionnaires. Med Sci Sports Exerc 2006 38 : 1584 92.
19. Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø Study. J Neurol 2005 253 : 464 70.
20. Vieth R, Bischoff-Ferrari H, Boucher BJ et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007 85 : 649 50.
21. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007 85 : 6 18.
22. Vieth R, Kimball S, Hu A, Walfish PG. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J 2004 3 : 8.
23. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006 84 : 18 28.
24. Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 2006 166 : 424 30.
25. Weaver DR, Deeds JD, Lee K, Segre GV. Localization of parathyroid hormone-related peptide (PTHrP) and PTH/PTHrP receptor mRNAs in rat brain. Brain Res Mol Brain Res 1995 28 : 296 310.
26. Smogorzewski MJ. Central nervous dysfunction in uremia. Am J Kidney Dis 2001 38 (Suppl. 1 S122 8.
27. Padwal R, Li SK, Lau DCW. Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Int J Obesity 2003 27 : 1437 46.